Accéder au contenu
Merck

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression.

Current opinion in pharmacology (2002-01-12)
Johannes M H M Reul, Florian Holsboer
RÉSUMÉ

Corticotropin-releasing factor (CRF) and its related family members are implicated in stress-related disorders such as anxiety and depression. Recently, two new members of this neuropeptide family have been discovered in the brain: urocortin II (also known as stresscopin-related peptide) and urocortin III (also known as stresscopin). These urocortins are selective agonists for the CRF(2) receptor, show a distinct neuroanatomical localization and are involved in stress-coping responses such as anxiolysis. Thus, CRF, the urocortins and their receptors form an intricate network in the brain involved in the acute phase as well as the recovery phase of the stress response.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Corticotropin Releasing Factor human, rat, ≥95% (HPLC), powder